Len Teti Authors Article on New US Stock Repurchase Excise Tax for Canadian Tax Foundation’s “Perspectives on Tax Law & Policy”
March 16, 2023
Cravath partner J. Leonard Teti II authored an article in the Canadian Tax Foundation’s “Perspectives on Tax Law & Policy,” which was published in March 2023. The article, entitled “The New US Stock Repurchase Excise Tax,” examines the recently signed‑into‑law Inflation Reduction Act of 2022, which enacted a 1 percent excise tax on stock repurchases by public companies occurring after December 31, 2022. The article also reviews additional rules applicable to the tax introduced by the United States Department of the Treasury, areas of the tax that will need to be clarified through the Treasury’s rule-making process, and its implications for Canadian policymakers.
Related Practices & Industries
Authors
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
March 06, 2023
RELX’s Acquisition of Human API
On March 6, 2023, LexisNexis® Risk Solutions, part of RELX, a global provider of information‑based analytics and decision tools for professional and business customers, announced it has entered into a definitive agreement to acquire Human API, a leading provider of consumer‑driven health data to life insurance and healthcare customers. Cravath is representing RELX in connection with the transaction.
Deals & Cases
February 09, 2023
IBM’s Acquisition of StepZen
On February 8, 2023, IBM announced the acquisition of StepZen Inc, which developed a GraphQL server with a unique architecture that helps developers build GraphQL APIs quickly and with less code. Cravath is representing IBM in connection with the transaction.
Deals & Cases
February 02, 2023
FS Investments’ Combination with Portfolio Advisors, Creating $73 Billion Alternative Investment Firm
On February 2, 2023, FS Investments, a pioneer in the democratization of alternative investments with more than $35 billion in assets under management, and Portfolio Advisors, a global middle‑market private asset specialist with more than $38 billion in assets under management, announced they have entered into a definitive agreement to combine their firms. The combined company will be poised for growth with over $73 billion in assets under management, including a significant permanent capital base, and a robust distribution platform. Cravath is representing FS Investments in connection with the transaction.
Deals & Cases
February 01, 2023
Monogram Health Holdings’ Series C Financing Round
Cravath represented Monogram Health Holdings, Inc. in connection with its $375 million Series C financing round, consisting of a private placement of series C preferred stock. Monogram Health Holdings is the parent company of Monogram Health, Inc., a leading kidney‑disease‑focused benefit management and care delivery company. The transaction closed on December 23, 2022.
